Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Propionate pMDI vs Flovent HFA in Asthma
NCT03879837Phase 3Completed
- Sponsor
- Allergan
- Start
- Mar 2019
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in asthma, sponsored by Allergan. Started Mar 2019; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03879837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03879837.